Devyser Diagnostics AB (DVYSR) — Cash Flow Reinvestment Rate
Devyser Diagnostics AB (DVYSR) has a Cash Flow Reinvestment Rate of 0.02x as of March 2026, reinvesting Skr300.00K (capex Skr300.00K ) from operating cash flow of Skr12.10 Million. See cash generation quality of Devyser Diagnostics AB to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Devyser Diagnostics AB Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Devyser Diagnostics AB across 4 annual periods. For the full cash flow conversion analysis, see DVYSR operating cash flow.
Annual Cash Flow Reinvestment Rate for Devyser Diagnostics AB (2018–2025)
Year-by-year capital reinvestment analysis for Devyser Diagnostics AB. See financial agility of Devyser Diagnostics AB to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | Skr2.00 Million | Skr8.20 Million | Skr1.50 Million | ▼ -98.1% |
| 2020 | 12.96x | Skr8.13 Million | Skr627.00K | Skr3.41 Million | ▲ +1936.5% |
| 2019 | 0.64x | Skr9.31 Million | Skr14.63 Million | Skr9.31 Million | ▼ -24.3% |
| 2018 | 0.84x | Skr5.06 Million | Skr6.02 Million | Skr5.06 Million | — |